Home
>
National Drug Code (NDC)
>
Lithium Carbonate
Lithium Carbonate - 0054-4527-25 - (Lithium Carbonate)
Drug Information of Lithium Carbonate
| Product NDC: | 0054-4527 |
| Proprietary Name: | Lithium Carbonate |
| Non Proprietary Name: | Lithium Carbonate |
| Active Ingredient(s): | 300 mg/1 & nbsp; Lithium Carbonate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lithium Carbonate
| Product NDC: | 0054-4527 |
| Labeler Name: | Roxane Laboratories, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA018558 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19820129 |
Package Information of Lithium Carbonate
| Package NDC: | 0054-4527-25 |
| Package Description: | 100 TABLET in 1 BOTTLE (0054-4527-25) |
NDC Information of Lithium Carbonate
| NDC Code | 0054-4527-25 |
| Proprietary Name | Lithium Carbonate |
| Package Description | 100 TABLET in 1 BOTTLE (0054-4527-25) |
| Product NDC | 0054-4527 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Lithium Carbonate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19820129 |
| Marketing Category Name | ANDA |
| Labeler Name | Roxane Laboratories, Inc |
| Substance Name | LITHIUM CARBONATE |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Mood Stabilizer [EPC] |
